Ayala Pharmaceuticals Inc. (AYLA): Price and Financial Metrics

Ayala Pharmaceuticals Inc. (AYLA): $0.50

0.03 (+5.84%)

POWR Rating

Component Grades

Momentum

F

Stability

F

Sentiment

Quality

C

Add AYLA to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#246 of 380

in industry

AYLA Price/Volume Stats

Current price $0.50 52-week high $7.31
Prev. close $0.48 52-week low $0.36
Day low $0.44 Volume 137,700
Day high $0.57 Avg. volume 76,300
50-day MA $0.53 Dividend yield N/A
200-day MA $1.37 Market Cap 7.46M

AYLA Stock Price Chart Interactive Chart >


Ayala Pharmaceuticals Inc. (AYLA) Company Bio


Ayala Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, which is an intravenous injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, an oral injectable small molecule GSI that is in Phase I clinical trial for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was founded in 2017 and is based in Rehovot, Israel.


AYLA Latest News Stream


Event/Time News Detail
Loading, please wait...

AYLA Latest Social Stream


Loading social stream, please wait...

View Full AYLA Social Stream

AYLA Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -94.62%
5-year N/A
YTD N/A
2023 0.00%
2022 -95.30%
2021 -22.64%
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!